A new non-radioactive method for the screening and prenatal diagnosis of myotonic dystrophy patients

Raffaella Brugnoni, Lucia Morandi, Bruno Brambati, Vincenza Briscioli, Ferdinando Cornelio, Renato Mantegazza

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease with an estimated incidence of 1 in 8000 and is the most common form of muscular dystrophy affecting adults. An unstable, untranslated part of the myotonic dystrophy protein kinase gene on the long arm of chromosome 19, composed of CTG repeats, is a genetic marker for DM. We have developed a fast non-radioactive polymerase chain reaction (PCR) procedure to detect the (CTG)(n) repeat expansion in DM patients and their relatives. Genomic DNA extracted from peripheral blood lymphocytes was amplified by PCR using specific primers to flank the region containing the triplets. To improve the amplification of this CG-rich region, either 10% glycerol or rTth DNA polymerase XL (extra long) was added to the reaction mixture, allowing amplification of huge expansions otherwise not polymerized by PCR. The PCR products were Southern blotted and the expansion revealed using a fluorescein-labelled (CTG)10 probe. We compared our results with those obtained in 24 patients and relatives using genomic digestion followed by radioactive Southern blot; in all cases the results overlapped. The same technique was used for prenatal diagnosis in pregnant DM mothers. We conclude that this new method is reliable for the genetic testing of DM patients.

Original languageEnglish
Pages (from-to)289-293
Number of pages5
JournalJournal of Neurology
Volume245
Issue number5
DOIs
Publication statusPublished - 1998

Fingerprint

Myotonic Dystrophy
Prenatal Diagnosis
Polymerase Chain Reaction
Chromosomes, Human, Pair 19
Neuromuscular Diseases
Muscular Dystrophies
Genetic Testing
DNA-Directed DNA Polymerase
Southern Blotting
Fluorescein
Genetic Markers
Glycerol
Digestion
Mothers
Lymphocytes
DNA
Incidence
Genes

Keywords

  • CTG repeats
  • Myotonic dystrophy
  • Non-radioactive method

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

A new non-radioactive method for the screening and prenatal diagnosis of myotonic dystrophy patients. / Brugnoni, Raffaella; Morandi, Lucia; Brambati, Bruno; Briscioli, Vincenza; Cornelio, Ferdinando; Mantegazza, Renato.

In: Journal of Neurology, Vol. 245, No. 5, 1998, p. 289-293.

Research output: Contribution to journalArticle

Brugnoni, Raffaella ; Morandi, Lucia ; Brambati, Bruno ; Briscioli, Vincenza ; Cornelio, Ferdinando ; Mantegazza, Renato. / A new non-radioactive method for the screening and prenatal diagnosis of myotonic dystrophy patients. In: Journal of Neurology. 1998 ; Vol. 245, No. 5. pp. 289-293.
@article{23936748b50e4bae9282eac418cd70a6,
title = "A new non-radioactive method for the screening and prenatal diagnosis of myotonic dystrophy patients",
abstract = "Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease with an estimated incidence of 1 in 8000 and is the most common form of muscular dystrophy affecting adults. An unstable, untranslated part of the myotonic dystrophy protein kinase gene on the long arm of chromosome 19, composed of CTG repeats, is a genetic marker for DM. We have developed a fast non-radioactive polymerase chain reaction (PCR) procedure to detect the (CTG)(n) repeat expansion in DM patients and their relatives. Genomic DNA extracted from peripheral blood lymphocytes was amplified by PCR using specific primers to flank the region containing the triplets. To improve the amplification of this CG-rich region, either 10{\%} glycerol or rTth DNA polymerase XL (extra long) was added to the reaction mixture, allowing amplification of huge expansions otherwise not polymerized by PCR. The PCR products were Southern blotted and the expansion revealed using a fluorescein-labelled (CTG)10 probe. We compared our results with those obtained in 24 patients and relatives using genomic digestion followed by radioactive Southern blot; in all cases the results overlapped. The same technique was used for prenatal diagnosis in pregnant DM mothers. We conclude that this new method is reliable for the genetic testing of DM patients.",
keywords = "CTG repeats, Myotonic dystrophy, Non-radioactive method",
author = "Raffaella Brugnoni and Lucia Morandi and Bruno Brambati and Vincenza Briscioli and Ferdinando Cornelio and Renato Mantegazza",
year = "1998",
doi = "10.1007/s004150050220",
language = "English",
volume = "245",
pages = "289--293",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "5",

}

TY - JOUR

T1 - A new non-radioactive method for the screening and prenatal diagnosis of myotonic dystrophy patients

AU - Brugnoni, Raffaella

AU - Morandi, Lucia

AU - Brambati, Bruno

AU - Briscioli, Vincenza

AU - Cornelio, Ferdinando

AU - Mantegazza, Renato

PY - 1998

Y1 - 1998

N2 - Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease with an estimated incidence of 1 in 8000 and is the most common form of muscular dystrophy affecting adults. An unstable, untranslated part of the myotonic dystrophy protein kinase gene on the long arm of chromosome 19, composed of CTG repeats, is a genetic marker for DM. We have developed a fast non-radioactive polymerase chain reaction (PCR) procedure to detect the (CTG)(n) repeat expansion in DM patients and their relatives. Genomic DNA extracted from peripheral blood lymphocytes was amplified by PCR using specific primers to flank the region containing the triplets. To improve the amplification of this CG-rich region, either 10% glycerol or rTth DNA polymerase XL (extra long) was added to the reaction mixture, allowing amplification of huge expansions otherwise not polymerized by PCR. The PCR products were Southern blotted and the expansion revealed using a fluorescein-labelled (CTG)10 probe. We compared our results with those obtained in 24 patients and relatives using genomic digestion followed by radioactive Southern blot; in all cases the results overlapped. The same technique was used for prenatal diagnosis in pregnant DM mothers. We conclude that this new method is reliable for the genetic testing of DM patients.

AB - Myotonic dystrophy (DM) is an autosomal dominant neuromuscular disease with an estimated incidence of 1 in 8000 and is the most common form of muscular dystrophy affecting adults. An unstable, untranslated part of the myotonic dystrophy protein kinase gene on the long arm of chromosome 19, composed of CTG repeats, is a genetic marker for DM. We have developed a fast non-radioactive polymerase chain reaction (PCR) procedure to detect the (CTG)(n) repeat expansion in DM patients and their relatives. Genomic DNA extracted from peripheral blood lymphocytes was amplified by PCR using specific primers to flank the region containing the triplets. To improve the amplification of this CG-rich region, either 10% glycerol or rTth DNA polymerase XL (extra long) was added to the reaction mixture, allowing amplification of huge expansions otherwise not polymerized by PCR. The PCR products were Southern blotted and the expansion revealed using a fluorescein-labelled (CTG)10 probe. We compared our results with those obtained in 24 patients and relatives using genomic digestion followed by radioactive Southern blot; in all cases the results overlapped. The same technique was used for prenatal diagnosis in pregnant DM mothers. We conclude that this new method is reliable for the genetic testing of DM patients.

KW - CTG repeats

KW - Myotonic dystrophy

KW - Non-radioactive method

UR - http://www.scopus.com/inward/record.url?scp=0031972152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031972152&partnerID=8YFLogxK

U2 - 10.1007/s004150050220

DO - 10.1007/s004150050220

M3 - Article

C2 - 9617710

AN - SCOPUS:0031972152

VL - 245

SP - 289

EP - 293

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 5

ER -